Vol 1, No 4 (2009)

Mol Cell Pharmacol

Table of Contents


Abuse Potential of Soma®: the GABAA Receptor as a Target Abstract PDF
Lorie A. Gonzalez, Michael B. Gatch, Michael J. Forster, Glenn H. Dillon 180-186
Voglibose, an Alpha-glucosidase Inhibitor, to Increase Active Glucagon-like Peptide-1 Levels Abstract PDF
Yusuke Moritoh, Koji Takeuchi, Masatoshi Hazama 188-192
Targeting Chronic Pain with Epigenetic Drugs: Focus on mGlu2 Receptors Abstract PDF
Santina Chiechio, Magda Zammataro, Robert W. Gereau IV, Agata Copani, Ferdinando Nicoletti 194-199

Research Articles

Human Prostate Cancer Cells Secrete Neuro-Protective Factors in Response to Cryotherapy Abstract PDF
Seema Gupta, Mini Varghese, Mohammed M. Shareef, Mansoor M. Ahmed 200-206
Enhancement of Gamma Radiation-induced Cytotoxicity of Breast Cancer Cells by Curcumin Abstract PDF
Swati Girdhani, Mansoor M. Ahmed, Kaushala P. Mishra 208-217


Seleno-L-Methionine Modulation of Nucleotide Excision DNA Repair Relevant to Cancer Prevention and Chemotherapy Abstract PDF
Martin L. Smith, M.A. Suresh Kumar 218-221
Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy Abstract PDF
Jaclyn L. Kovach, Stephen G. Schwartz 222-227


Corrigendum to: Differentiation of cochlear neural progenitors with SV40 in vitro. Mol Cell Pharmacol 2009;1:11-22 PDF
Jizhen Lin 228

FDA Corner

FDA Approves New Drug to Treat Psoriasis Abstract PDF
FDA Approves First Drug for Treatment of Peripheral T-cell Lymphoma Abstract PDF
FDA Approves Vaccines for 2009 H1N1 Influenza Virus Abstract PDF
FDA Approves New Cholesterol-Lowering Drug Abstract PDF

LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.